AMBRISENTAN Devatis cpr pell 5 mg 10 pce
7680677990014
CH-67799
C02KX02
02.07.1.
Reimbursement limitations:
VOLIBRIS
Traitement de l’hypertension artérielle pulmonaire idiopathique (HTAPI) et de l’HTAP associée à des affections de …
1 / 3
google
Details
- Product number
- 6779901
- CPT
- -
- Packaging group
- 10
- Unit
- Tablette(n)
- Composition
- Filmtablette: ambrisentanum 5 mg, lactosum monohydricum 70.725 mg, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium 187 µg, magnesii stearas, Überzug: poly(alcohol vinylicus), talcum, macrogolum 3350, lecithinum ex soja, E 171, E 129 42.3 µg, pro compresso obducto.
Articles (1)
Ambrisentan Devatis 5 mg, Filmtabletten
Filmtabletten
10
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
FTAB
|
5.0 MG | Substance | Wirkstoff (Principe actif) |
|
FTAB
|
70.725 MG | Substance | HBESI |
|
FTAB
|
- | Substance | HNIDK |
|
FTAB
|
- | Substance | HNIDK |
|
FTAB
|
187.0 UG | Substance | HBESI |
|
FTAB
|
- | Substance | HNIDK |
|
FTAB
|
- | Substance | HNIDK |
|
FTAB
|
- | Substance | HNIDK |
|
FTAB
|
- | Substance | HNIDK |
|
FTAB
|
- | Substance | HNIDK |
|
FTAB
|
- | Substance | FNIDK |
|
FTAB
|
42.3 UG | Substance | HBESI |
Authorization holder
Devatis AG
6330 Cham
Authorization information
- Swissmedic authorization number
- 67799
- Drug name
- Ambrisentan Devatis, Filmtabletten
- Galenic form
- FILM
- ATC Code
- C02KX02
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 29/10/2020
- Authorization expiration date
- 31/12/9999
- IT number
- 02.07.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- AMBRISENTAN Devatis cpr pell 5 mg 10 pce
- Description (DE)
- AMBRISENTAN Devatis Filmtabl 5 mg 10 Stk
- Market launch
- 29/10/2020
- Narcotic (BTM)
- No